ADC products

R&D

Partner Content

The 3rd ADC Analytical Development Summit is your only industry-dedicated meeting providing you with the key insights to ensure y

News

AbbVie's bid to bring a rapid and shorter-acting botulinum toxin product to the US market has been knocked back by the FDA.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.